Arimoclomol for treating glucocerebrosidase associated disorders

Abstract The present invention relates to an active pharmaceutical ingredient selected from N [2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof (arimoclomol), for use in a method of 5 treating glucocerebrosidase ass...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HINSBY, Anders Mørkeberg, PETERSEN, Nikolaj Havnsøe Torp, FOG-TONNESEN, Cathrine Kolster, BORNÆS, Claus, JENSEN, Thomas Kirkegaard
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HINSBY, Anders Mørkeberg
PETERSEN, Nikolaj Havnsøe Torp
FOG-TONNESEN, Cathrine Kolster
BORNÆS, Claus
JENSEN, Thomas Kirkegaard
description Abstract The present invention relates to an active pharmaceutical ingredient selected from N [2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof (arimoclomol), for use in a method of 5 treating glucocerebrosidase associated disorders.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020277270BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020277270BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020277270BB23</originalsourceid><addsrcrecordid>eNqNyjEOwjAMRuEsDAi4QwZWpCoMWWkrEAeAuTLO3ypSWld2uD8MHAC94Vve1l1azbNwkVmKH0V9VVDNy-Sn8mZhKF4qlhMZPJkJZ6pIPmUTTVDbu81IxXD4uXPH2_XR309YZYCtxFhQh_YZmm8xhth0XTj_uX0AbVIzog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Arimoclomol for treating glucocerebrosidase associated disorders</title><source>esp@cenet</source><creator>HINSBY, Anders Mørkeberg ; PETERSEN, Nikolaj Havnsøe Torp ; FOG-TONNESEN, Cathrine Kolster ; BORNÆS, Claus ; JENSEN, Thomas Kirkegaard</creator><creatorcontrib>HINSBY, Anders Mørkeberg ; PETERSEN, Nikolaj Havnsøe Torp ; FOG-TONNESEN, Cathrine Kolster ; BORNÆS, Claus ; JENSEN, Thomas Kirkegaard</creatorcontrib><description>Abstract The present invention relates to an active pharmaceutical ingredient selected from N [2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof (arimoclomol), for use in a method of 5 treating glucocerebrosidase associated disorders.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230223&amp;DB=EPODOC&amp;CC=AU&amp;NR=2020277270B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230223&amp;DB=EPODOC&amp;CC=AU&amp;NR=2020277270B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HINSBY, Anders Mørkeberg</creatorcontrib><creatorcontrib>PETERSEN, Nikolaj Havnsøe Torp</creatorcontrib><creatorcontrib>FOG-TONNESEN, Cathrine Kolster</creatorcontrib><creatorcontrib>BORNÆS, Claus</creatorcontrib><creatorcontrib>JENSEN, Thomas Kirkegaard</creatorcontrib><title>Arimoclomol for treating glucocerebrosidase associated disorders</title><description>Abstract The present invention relates to an active pharmaceutical ingredient selected from N [2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof (arimoclomol), for use in a method of 5 treating glucocerebrosidase associated disorders.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEOwjAMRuEsDAi4QwZWpCoMWWkrEAeAuTLO3ypSWld2uD8MHAC94Vve1l1azbNwkVmKH0V9VVDNy-Sn8mZhKF4qlhMZPJkJZ6pIPmUTTVDbu81IxXD4uXPH2_XR309YZYCtxFhQh_YZmm8xhth0XTj_uX0AbVIzog</recordid><startdate>20230223</startdate><enddate>20230223</enddate><creator>HINSBY, Anders Mørkeberg</creator><creator>PETERSEN, Nikolaj Havnsøe Torp</creator><creator>FOG-TONNESEN, Cathrine Kolster</creator><creator>BORNÆS, Claus</creator><creator>JENSEN, Thomas Kirkegaard</creator><scope>EVB</scope></search><sort><creationdate>20230223</creationdate><title>Arimoclomol for treating glucocerebrosidase associated disorders</title><author>HINSBY, Anders Mørkeberg ; PETERSEN, Nikolaj Havnsøe Torp ; FOG-TONNESEN, Cathrine Kolster ; BORNÆS, Claus ; JENSEN, Thomas Kirkegaard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020277270BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HINSBY, Anders Mørkeberg</creatorcontrib><creatorcontrib>PETERSEN, Nikolaj Havnsøe Torp</creatorcontrib><creatorcontrib>FOG-TONNESEN, Cathrine Kolster</creatorcontrib><creatorcontrib>BORNÆS, Claus</creatorcontrib><creatorcontrib>JENSEN, Thomas Kirkegaard</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HINSBY, Anders Mørkeberg</au><au>PETERSEN, Nikolaj Havnsøe Torp</au><au>FOG-TONNESEN, Cathrine Kolster</au><au>BORNÆS, Claus</au><au>JENSEN, Thomas Kirkegaard</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Arimoclomol for treating glucocerebrosidase associated disorders</title><date>2023-02-23</date><risdate>2023</risdate><abstract>Abstract The present invention relates to an active pharmaceutical ingredient selected from N [2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof (arimoclomol), for use in a method of 5 treating glucocerebrosidase associated disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2020277270BB2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Arimoclomol for treating glucocerebrosidase associated disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HINSBY,%20Anders%20M%C3%B8rkeberg&rft.date=2023-02-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020277270BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true